Thus, the selective response of AML cells to CP-EPS8-NLS treatment might be a consequence of a CP-EPS8-NLS mediated loss of the nuclear localization function of EPS8 and subsequent downregulation of EPS8. This evidence concerns the gene CP and acute myeloid leukemia.